Gentherm Inc (THRM): Completion of Acquisition or Disposition of Assets
Gentherm Inc (THRM) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 thrm-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization Revenue Growth of 9.5% (ex-FX) Year-over-Year Delivered Record Quarterly Revenue of $416 Million 2026 Full Year Guidanc
How this was made
The 30-second read
Why it matters
Traders can update valuation and positioning based on the raised guidance ranges (product revenues, adjusted EBITDA, adjusted free cash flow) and the incremental capital return authorization, while monitoring integration and cash flow normalization given restructuring and M&A expenses.
Market read
This is a multi-catalyst update: raised FY2026 guidance, a new $400M repurchase authorization, and transaction completion details, which together can drive repricing and near-term positioning changes.
What to watch
The guidance explicitly assumes tariffs and a specific EUR/USD rate, and it does not reflect impacts from the planned Modine combination, which could create timing gaps between expectations and realized results.
Background
The 8-K reports Item 2.01 completion of an acquisition/disposition of assets and includes an earnings release with raised FY2026 guidance, plus updates on the planned Modine Performance Technologies combination and a new repurchase program.
Ticker impact
Gentherm completed the 8-K Item 2.01 asset acquisition/disposition and also raised 2026 guidance, plus authorized a new $400M buyback.
Near-term upside bias, with volatility tied to how the completed acquisition and the Modine combination progress into early Q4 2026.
The article discloses multiple fresh, decision-relevant datapoints: raised full-year guidance ranges, a new $400M repurchase authorization, and completion of key sign-to-close deliverables for the Modine combination, alongside the completed asset transaction under Item 2.01.
Market effects
Could modestly improve sentiment for automotive thermal management and medical thermal therapy suppliers via read-across on demand and margin discipline.
Limited direct regional impact; primarily US-listed industrial/auto-supplier sentiment.
Global auto production and FX assumptions are explicitly referenced in guidance, which may influence peers’ modeling of similar exposures.
Counterpoint
Cash flow from operations fell sharply year over year, and gross margin declined, so the guidance raise may rely on assumptions that could prove fragile.
Key entities
- companyGentherm Inc
NASDAQ-listed thermal management and pneumatic comfort technologies provider; raised FY2026 guidance and authorized a new $400M buyback, with an acquisition/disposition completion disclosed under Item 2.01.
- companyModine Performance Technologies
Planned combination counterparty; the filing states key sign-to-close deliverables are completed and the deal remains on track for early Q4 2026 close.
- companyInnovative Medical Equipment, LLC
Acquired entity described as provider of the ThermaZone thermal therapy device, expanding Gentherm’s medical portfolio and cross-selling opportunities.
